Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the effectiveness in using subcutaneous 5-FU/Kenalog \& topical Maxitrol Ophthalmic ointment as different therapeutic adjuncts in the prevention of pathologic remodeling after periorbital burns.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
February 28, 2026
Primary Completion Date
November 1, 2026
Completion Date
January 1, 2027
Last Updated
January 16, 2026
10
ESTIMATED participants
Steroid/Antibiotic (Maxitrol)
DRUG
5-FU/Kenalog
DRUG
Lead Sponsor
Virginia Commonwealth University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions